Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GO TEST FINALE
2020-005730-15Phase 4Active
- Sponsor
- Sint Maartenskliniek
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of allopurinol, benzbromarone and febuxostat in gout (2 arms), sponsored by Sint Maartenskliniek. Primary endpoint: Proportion of patients in remission during the last 6 months of 24 months follow-up. Started Jan 2021; status: active.
02
Drugs
allopurinolbenzbromaronefebuxostat
03
Conditions
gout
Beyond the preview
Go deeper on 2020-005730-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005730-15.